The cutting edge tip of the Acquire^TM needle (Boston Scientific Co., Natick, MA, USA) is symmetrically structured on three sides, with the shape designed to minimize resistance to accurate target and needle penetration (Fig. 1). The geometric needle structure, incorporating small and large inclination angles, is shaped like a crown, and is designed for deeper insertion to support core biopsies. The first retrospective study of this Franseen tip needle reported that both diagnostic adequacy and accuracy was >95% [2]. The first prospective randomized trial by the same researchers reported no difference in yielding histological tissue compared with the fork-tip needle [3]. However, another study, although not a prospective randomized controlled trial, reported that the fork-tip needle was superior, especially when diagnosing a pancreatic mass [4]. In a realistic situation where ROSE is not available, this discrepancy could be larger. How many passes are needed to get the proper tissue without ROSE, which might result in more complications? [5]

In a recent study in Clinical Endoscopy, El Hajj et al. [6] reported on a randomized trial comparing the overall diagnostic performance between this 22-G Franseen needle and the historical FNA needle in sampling solid tumors. In addition, the study evaluated the number of needle passes and the cytological quality of smears required to enable immediate ROSE. They demonstrated the superiority of the Franseen needle through cytological and histological scoring systems (2.32 vs. 2.02, p=0.046) and demonstrated that fewer passes are needed (2.88 vs. 3.82, p<0.001). There were no serious complications as a result of the procedure. The target tissues obtained using the core biopsy needles were obtained mainly as fragments. The authors compared these using smears and cell block technique instead of histological examination to determine the feasibility of ROSE. In addition, they showed various histologic samples and explained in detail how they were assessed.

The newly released EchoTip ProCore^® (Cook Medical, Bloomington, IN, USA) has been designed to complement the pros and cons of the existing ProCore^® needle (Fig. 2A). The 20-G needle was designed to match the size of the tissue with the flexibility of the needle. To enable core sampling, the direction of the oblique hole of the shaft was made opposite to that of the previous needle. The improved flexibility has made it easier to insert the needle and obtain a core biopsy, even in difficult anatomic locations when compared with the previous needle. Although a meta-analysis study of the ProCore^® needle showed no difference from conventional FNA needles in terms of diagnostic adequacy, diagnostic accuracy, or core biopsy acquisition rate, the number of needle passes required for diagnosis was significantly lower when using the ProCore^® needle [7]. Recent studies using the new 20-G core biopsy needles indicated improved results [8-10].

The six distal cutting edges of SharkCore^TM needle (Medtronic Inc., Minneapolis, MN, USA) were designed to be precisely inserted into the center of the tissue without disturbing the tissue architecture (Fig. 2B). The name of this needle is inspired by the shape of a shark’s mouth. This fork-tip needle enables core sampling, with minimized tissue stacking and fracturing (even for severely fibrotic lesions), and enhanced diagnostic yield. Results of initial studies reported a tissue acquisition rate of more than 90% and a diagnostic accuracy of 83%–93% [11-14].

In order to improve accessibility, EZ Shot 3 Plus (Olympus, Tokyo, Japan) was changed from conventional stainless steel to Nitinol, and the covering material was changed from plastic to a coil (Fig. 2C). These changes increased the tissue acquisition rate in the head of the pancreas, which due to the required angle, is deemed to be the most difficult location to obtain tissue. Furthermore, these changes prevented the Nitinol needle from deflecting, despite multiple insertions. In addition, due to the product being released at a lower price, it can be considered competitive with relatively expensive products designed by other companies.

The Moray^TM Micro Forceps (US endoscopy, Mentor, OH, USA) are designed to acquire the inner tissue of cystic lesions as opposed to fluid analysis using EUS-FNA (through-the-needle biopsy forceps) (Fig. 2D). These biopsy forceps can be inserted through all 19-G EUS-FNA needles of other companies, and positive results have been reported [15-17].

There is no doubt that the newer needles currently in use, and those that are continually being developed, will yield better results. In considering these needles for practice it is vital to examine not only the shortened procedure time and accuracy of the test, but also how conveniently and easily the exam can be performed (especially at the head of the pancreas), as well as to objectively evaluate whether the test can be completed safely. It is hoped that further studies will involve research into these areas.